Senescent HPMCs were proven to modulate cancer cells by secreting IL-6 and TGF-β1, promoting tumor vascularization through HIF-1α, NF-κb/p50, and AP-1/c-Jun pathways [134]. Here, JUN is linked to neoplasm.